These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26596284)

  • 1. CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.
    Nanda V; Downing KP; Ye J; Xiao S; Kojima Y; Spin JM; DiRenzo D; Nead KT; Connolly AJ; Dandona S; Perisic L; Hedin U; Maegdefessel L; Dalman J; Guo L; Zhao X; Kolodgie FD; Virmani R; Davis HR; Leeper NJ
    Circ Res; 2016 Jan; 118(2):230-40. PubMed ID: 26596284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient CDKN2B Expression: A Double Hit for PAD.
    Hess DL; Annex BH
    Circ Res; 2016 Jan; 118(2):190-2. PubMed ID: 26838310
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
    Kojima Y; Downing K; Kundu R; Miller C; Dewey F; Lancero H; Raaz U; Perisic L; Hedin U; Schadt E; Maegdefessel L; Quertermous T; Leeper NJ
    J Clin Invest; 2014 Mar; 124(3):1083-97. PubMed ID: 24531546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.
    Leeper NJ; Raiesdana A; Kojima Y; Kundu RK; Cheng H; Maegdefessel L; Toh R; Ahn GO; Ali ZA; Anderson DR; Miller CL; Roberts SC; Spin JM; de Almeida PE; Wu JC; Xu B; Cheng K; Quertermous M; Kundu S; Kortekaas KE; Berzin E; Downing KP; Dalman RL; Tsao PS; Schadt EE; Owens GK; Quertermous T
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):e1-e10. PubMed ID: 23162013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
    Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
    Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.
    Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S
    Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9p21.3 Coronary Artery Disease Risk Variants Disrupt TEAD Transcription Factor-Dependent Transforming Growth Factor β Regulation of p16 Expression in Human Aortic Smooth Muscle Cells.
    Almontashiri NA; Antoine D; Zhou X; Vilmundarson RO; Zhang SX; Hao KN; Chen HH; Stewart AF
    Circulation; 2015 Nov; 132(21):1969-78. PubMed ID: 26487755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
    Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
    J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.
    Klutho PJ; Pennington SM; Scott JA; Wilson KM; Gu SX; Doddapattar P; Xie L; Venema AN; Zhu LJ; Chauhan AK; Lentz SR; Grumbach IM
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2594-604. PubMed ID: 26449752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BubR1 insufficiency impairs angiogenesis in aging and in experimental critical limb ischemic mice.
    Okadome J; Matsumoto T; Yoshiya K; Matsuda D; Tamada K; Onimaru M; Nakano K; Egashira K; Yonemitsu Y; Maehara Y
    J Vasc Surg; 2018 Aug; 68(2):576-586.e1. PubMed ID: 28974341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of vascular smooth muscle cell calcification by syndecan-4/FGF-2/PKCα signalling and cross-talk with TGFβ.
    Borland SJ; Morris TG; Borland SC; Morgan MR; Francis SE; Merry CLR; Canfield AE
    Cardiovasc Res; 2017 Nov; 113(13):1639-1652. PubMed ID: 29016732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell proliferation through phosphorylation of the orphan nuclear receptor NOR1.
    Medunjanin S; Daniel JM; Weinert S; Dutzmann J; Burgbacher F; Brecht S; Bruemmer D; Kähne T; Naumann M; Sedding DG; Zuschratter W; Braun-Dullaeus RC
    Cardiovasc Res; 2015 Jun; 106(3):488-97. PubMed ID: 25852083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1).
    Bertorello AM; Pires N; Igreja B; Pinho MJ; Vorkapic E; Wågsäter D; Wikström J; Behrendt M; Hamsten A; Eriksson P; Soares-da-Silva P; Brion L
    Circ Res; 2015 Feb; 116(4):642-52. PubMed ID: 25556206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between macrophages and smooth muscle cells impairs collagen and metalloprotease synthesis and promotes angiogenesis.
    Butoi E; Gan AM; Tucureanu MM; Stan D; Macarie RD; Constantinescu C; Calin M; Simionescu M; Manduteanu I
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1568-78. PubMed ID: 27060293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.
    Jarinova O; Stewart AF; Roberts R; Wells G; Lau P; Naing T; Buerki C; McLean BW; Cook RC; Parker JS; McPherson R
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1671-7. PubMed ID: 19592466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
    Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of chromosome 9p21 noncoding cardiovascular risk interval in mice alters Smad2 signaling and promotes vascular aneurysm.
    Loinard C; Basatemur G; Masters L; Baker L; Harrison J; Figg N; Vilar J; Sage AP; Mallat Z
    Circ Cardiovasc Genet; 2014 Dec; 7(6):799-805. PubMed ID: 25176937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.